Symphogen
Hedvig Sofie Hasemann has extensive work experience in the pharmaceutical industry. Hedvig Sofie worked at Symphogen from 2018 to present as a Senior Scientist and Drug Product Coordinator. Prior to that, they worked at Novo Nordisk from 2004 to 2018, where they held various roles including Senior Research Scientist and Research Scientist. Hedvig Sofie also briefly worked as a Pharmacist at Nykøbing Apotek. Throughout their career, Hedvig Sofie Hasemann has been involved in developing new biopharmaceutical products and preparing documentation for their registration. Hedvig Sofie has gained experience in formulation science, freeze-drying processes, and quality testing.
Hedvig Sofie Hasemann completed their high school education at Odsherreds Gymnasium from 1998 to 2002. Hedvig Sofie then pursued their higher education at Danmarks Farmaceutiske Universitet, where they obtained a degree in cand.pharm. from 2003 to 2009. No specific field of study was mentioned for either of their degrees.
Symphogen
3 followers
Symphogen is a clinical-stage antibody oncology focused company with a differentiated product pipeline and significant commercial opportunities. Inspired by nature, led by science and driven by people, we passionately strive to make that discovery that may have great effect on the lives of patients, their families, and their caregivers. Based on our monoclonal antibody (mAb) research platform, we create differentiated mAb and mAb mixture products candidates. Our pre-clinical and clinical pipeline is well suited for a precision-medicine approach by addressing well-defined, biomarker-selected patient populations. We are headquartered in Denmark with operations in the US.